21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V
Pieris Pharma US Patent & Trademark Office Abstract Filed For Co.’s ‘Proteins specific for calcitonin gene-related peptide’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5518&f=G&l=50&d=PTXT&p=111&S1=20210615&OS=20210615&RS=20210615
Pieris Pharmaceuticals Granted U.S. Patent ‘Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5517&f=G&l=50&d=PTXT&p=111&S1=20210615&OS=20210615&RS=20210615
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.
60 Biggest Movers From Yesterday
Gainers
Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related logistics assets.
What’s Going On With Pieris Pharmaceuticals Stock Today?
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher by 57% at $2.91 after the company announced a respiratory and ophthalmology collaboration with Genentech.
Earnings Scheduled For May 17, 2021
Companies Reporting Before The Bell
• Hycroft Mining Holding (NASDAQ:HYMC) is estimated to report earnings for its first quarter.
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.